Generate a tailored SOP for Dr. Nina Refhagen. Improve your application with a focused, well-structured draft.
Nina Refhagen is a doctoral student at Umeå University, focusing on research related to pediatric T-cell acute lymphoblastic leukemia. Her work contributes to the understanding of methylator phenotype classification, which plays a critical role in risk assessment for this particular type of leukemia. She is actively involved in various research initiatives and collaborations within her field. Refhagen has co-authored multiple publications, reflecting her growing expertise in cancer research. Her academic contributions are underpinned by a strong commitment to advancing knowledge in medical science, particularly concerning hematology and oncology. She is part of a research group led by Sofie Degerman, where collaborative efforts are key to identifying innovative solutions and exploring new methodologies in genetic research and treatment strategies.
Umeå University • Umeå, Sweden
Engaged in doctoral research focusing on pediatric T-cell acute lymphoblastic leukemia, specifically exploring the implications of CpG island methylator phenotype classification.
Requirements are standard for Master's programs across Social Sciences and Humanities at Umeå. English 6 proficiency is the general rule.